Panamera Holdings Corporation PHCI

Q3 FY2026 · ended Apr 30, 2026 · Revenue $0, -100.0% YoY · Filed Jun 22, 2026

Panamera Holdings Corporation (PHCI) files with the SEC under industry code 8742, Services-Management Consulting Services. In Q3 of fiscal 2026, the quarter ended Apr 30, 2026, it reported revenue of $0 and a net loss of $116,515. As of Apr 30, 2026 it held $46 in cash and investments and $35,306 in total debt.

Revenue
$0
-100.0% vs year-ago quarter
Net income
$-116,515
-0.6% vs year-ago quarter
Operating cash flow
$-44,715
+73.3% vs year-ago quarter
Free cash flow
$-306,759
-83.4% vs prior quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
79.89M
+52.6% vs year-ago quarter
Net cash
$-35,260
Q3 FY2026
Operating margin
-81688.3%
TTM

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
PHCI (OTC)
Fiscal year ends
July 31
Incorporated in
NV
Headquarters
Houston, TX
SEC filer status
, Emerging growth company
SEC CIK
1620749
Former names
PANAMERA HEALTHCARE Corp (until Jun 16, 2021)

Other Services-Management Consulting Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Apr 30, 2026
Q2 FY2026
Jan 31, 2026
Q1 FY2026
Oct 31, 2025
Q4 FY2025
Jul 31, 2025
Q3 FY2025
Apr 30, 2025
Revenue
$0
$139,500
$0
$49,030
$69,342
Operating income
-$69,890
-$78,641
-$153.6M
-$243,020
-$115,463
Net income
-$116,515
-$126,599
-$153.7M
-$229,528
-$115,810
Diluted EPS
$0.00
$0.00
-$2.08
-$0.00
$0.00
Operating cash flow
-$44,715
-$22,827
-$218,481
-$306,759
-$167,274
Free cash flow
—
—
—
-$306,759
-$167,274
Total assets
$95,349
$124,893
$113,583
$803,519
$269,912
Total liabilities
$4.3M
$4.3M
$4.1M
$179,064
$265,679
Stockholders' equity
-$4.2M
-$4.1M
-$4.0M
$624,455
$4,233
Cash and investments
$46
$17,061
$47,888
$85,980
$150,274
Total debt
$35,306
$46,734
$57,996
$69,094
$80,031

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Restatement
Oct 26, 2026 Oct 26, 2026
10-Q Quarterly report Jun 22, 2026 Apr 30, 2026
8-K Current report
Officer or director change
Jun 22, 2026 Jun 19, 2026
8-K Current report
Officer or director change
May 12, 2026 May 12, 2026
10-Q Quarterly report Mar 23, 2026 Jan 31, 2026
10-Q Quarterly report Feb 17, 2026 Oct 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.